Mechanism & research context
ARA-290 (cibinetide) is an 11-residue peptide derived from the helix-B sequence of erythropoietin, binding the innate-repair receptor without erythropoietic activity. Research applications include neuropathy and tissue-protection models. Supplied as lyophilized powder at ≥98% HPLC purity.
Use disclaimerFor Research Use Only. Not for Human Consumption. Not a drug, food, or cosmetic.
Article reflects published preclinical and in-vitro literature. Additional citations available on request to research@peptitan.eu.